| 多发性硬化的治疗进展 |
| |
| 引用本文： | 郭丽萍. 多发性硬化的治疗进展[J]. 中国临床神经科学, 2012, 0(4): 440-444,448 |
| |
| 作者姓名： | 郭丽萍 |
| |
| 作者单位： | 中日友好医院,100029 |
| |
| 摘 要： | 多发性硬化（MS）是一种常见的中枢神经系统自身免疫性炎性脱髓鞘疾病，自身抗原激活T细胞和B细胞介导的免疫机制异常在MS的致病过程中起重要作用。MS改良治疗（DMTs）可特异性作用于某个与致病机制相关的靶细胞或分子而发挥治疗作用，本文就近年口服药物和单克隆抗体治疗MS的新进展做一综述。
|
| 关 键 词： | 多发性硬化 治疗 脱髓鞘疾病 |
Developing Treatment in Multiple Sclerosis |
| |
| GUO Li-Ping. Developing Treatment in Multiple Sclerosis[J]. Chinese Journal of Clinical Neurosciences, 2012, 0(4): 440-444,448 |
| |
| Authors: | GUO Li-Ping |
| |
| Affiliation: | GUO Li-Ping China-Japan Friendship Hospital, Beijing, 100029, China |
| |
| Abstract: | Multiple sclerosis（MS） is an inflammatory, demyelinating disease of central nervous system. MS is believed to be an autoaggressive disease mediated by autoreactive T and B cells. Promising disease-modifying therapies including biologic therapies or small molecules are encouraged for treating MS. The review about oral therapies and monoclonal antibodies for MS was provided. |
| |
| Keywords: | multiple sclerosis treatment demyelinating disease |
| 本文献已被 CNKI 维普 等数据库收录！ |
|
